Praxis Precision Medicines (PRAX) Prepaid Assets (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Prepaid Assets of $10.9 million for Q1 2026, up 95.36% year-over-year from $5.6 million in Q1 2025, and down 5.79% quarter-over-quarter from $11.6 million in Q4 2025.
Praxis Precision Medicines (PRAX) Prepaid Assets (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Prepaid Assets history runs 8 years deep, the most recent figure standing at $10.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 95.36% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $10.9 million (up 95.36% YoY), while the FY2025 annual figure was $11.6 million, down 1.91% from the prior year.
- Prepaid Assets for Q1 2026 stood at $10.9 million, down from $11.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $12.0 million in Q1 2022, with the low at $2.2 million in Q3 2023.
- The 5-year median for Prepaid Assets is $6.7 million (2025), against an average of $7.4 million.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets tumbled 73.85% in 2023, then surged 229.75% in 2024.
- Praxis Precision Medicines' Prepaid Assets stood at $10.4 million in 2022, then sank by 65.41% to $3.6 million in 2023, then soared by 229.75% to $11.8 million in 2024, then retreated by 1.91% to $11.6 million in 2025, then fell by 5.79% to $10.9 million in 2026.
- Business Quant data shows PRAX's Prepaid Assets at $10.9 million in Q1 2026, $11.6 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.10 Bn | 131.24 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.66 Bn | 76.67 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.59 Bn | 59.40 Bn | 1.37 Bn |
| 4 | Moderna | 60.02 Bn | 54.88 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.64 Bn | 36.55 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.90 Bn | 28.59 Bn | 992.69 Mn |
| 7 | Royalty Pharma | 27.38 Bn | 26.55 Bn | - |
| 8 | BioNTech SE | 27.36 Bn | 8.97 Bn | 668.28 Mn |
| 9 | Insmed | 26.66 Bn | 25.50 Bn | 358.27 Mn |
| 10 | Praxis Precision Medicines | 10.86 Bn | 10.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.35 Mn |
| Mar 31, 2026 | 10.91 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.58 Mn |
| Dec 31, 2024 | 11.81 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 4.84 Mn |
| Mar 31, 2024 | 4.39 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 2.24 Mn |
| Jun 30, 2023 | 5.53 Mn |
| Mar 31, 2023 | 8.58 Mn |
| Dec 31, 2022 | 10.35 Mn |
| Sep 30, 2022 | 8.57 Mn |
| Jun 30, 2022 | 10.18 Mn |
| Mar 31, 2022 | 11.96 Mn |
| Dec 31, 2021 | 11.50 Mn |
| Sep 30, 2021 | 4.97 Mn |